Fully biologically active when compared to standard. The ED50 determined by a chemotaxis bioassay using human THP-1 cells is less than 40 ng/ml, corresponding to a specific activity of >, 2.5 × 104 IU/mg.
Reinheit
> 97 % by SDS-PAGE and HPLC analyses.
Endotoxin-Niveau
Level Less than 1EU/µg of rHuMIP-3/CCL23 as determined by LAL method
CCL23
Spezies: Human
Wirt: HEK-293 Cells
Recombinant
> 80 % as determined by SDS-PAGE and Coomassie blue staining
AbP, STD
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at < -20 °C. Further dilutions should be made in appropriate buffered solutions.
MIP-3/CCL23 is a CC chemokine that signals through the CCR1 receptor. MIP-3 chemoattracts monocytes, resting T-lymphocytes and neutrophils, but does not chemoattract activated lymphocytes. Additionally, MIP-3 has been shown to inhibit colony formation of bone marrow myeloid immature progenitors. Alternative splicing of the MPIF1 gene results in two mRNAs that encode a short (CKbeta8) and a long (CKbeta81) isoform of the chemokine. CKbeta8 cDNA encodes a 120 amino acid (aa) residue precursor protein with a putative 21 aa residue signal peptide that is cleaved to generate a 99 aa residue mature CKbeta8 (aa 22 120). Additional N terminal processing of the 99 aa residue variant can generate a 75 aa residue CKbeta8 (aa 46 120) that is significantly more active than the 99 aa residue variant. Synonym: MIP-3/CCL23, Human. Formulation: Lyophilized from a 0.2µm filtered concentrated solution in 20mM PB, pH 7.4, 150mM NaCl.
Molekulargewicht
11.3 kDa, a single, non-glycosylated polypeptide chain containing 99 amino acids.